Clinical Trials Directory

Trials / Completed

CompletedNCT05818618

Impact of Topical Clobetasol on Gingival Crevicular Fluid miRNAs in Subjects Affected by Oral Lichen Planus

Impact of Topical Clobetasol on Gingival Crevicular Fluid miRNAs in Subjects Affected by Oral Lichen Planus: a Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
University of Catania · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

According to recent research, microRNAs (miRNAs) may function as early disease indicators and contribute to the severity of a number of precancerous and malignant oral disorders. The aim of the present study, through a double-blind randomized controlled trial design, is to analyze in the gingival crevicular fluid (GCF) as a non-invasive approach the impact of topical clobetasol on miRNAs expression in subjects affected by oral lichen planus (OLP).

Detailed description

A double-blind randomized controlled clinical trial is conducted in order to evaluate the impact of topical clobetasol on GCF miRNAs expression in subjects with OLP and determine the statistical significance of the outcome variables. At least 60 patients with OLP, randomly allocated in two groups: placebo group with a 4% hydroxyethyl cellulose adhesive gel and the clobetasol group with the same gel containing clobetasol propionate 0,05%.

Conditions

Interventions

TypeNameDescription
DRUGClobetasol Topical GelTopic Clobetasol gel applied locally on OLP lesions.
DRUGPlaceboPlacebo oral gel applied locally on OLP lesions.

Timeline

Start date
2020-03-12
Primary completion
2023-07-05
Completion
2023-08-10
First posted
2023-04-19
Last updated
2023-08-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05818618. Inclusion in this directory is not an endorsement.